Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society
|
April 7, 2012
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure
Shigeki Kobayashi, Takehisa Susa, Takeo Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 15, 2010
Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model
Shigeki Kobayashi, Masafumi Yano, Hitoshi Uchinoumi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 26, 2006
AT1 receptor antagonist restores cardiac ryanodine receptor function, rendering isoproterenol-induced failing heart less susceptible to Ca2+ -leak induced by oxidative stress
Takahiro Tokuhisa, Masafumi Yano, Masakazu Obayashi, et al.
Circulation
|
December 7, 2005
Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure
Masafumi Yano, Shinichi Okuda, Tetsuro Oda, et al.
European Journal of Heart Failure
|
October 23, 2010
Urinary 8-hydroxy-2'-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure
Shigeki Kobayashi, Takehisa Susa, Takeo Tanaka, et al.
Biochemical and Biophysical Research Communications
|
March 16, 2010
Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction
Xiaojuan Xu, Masafumi Yano, Hitoshi Uchinoumi, et al.
Circulation Research
|
March 13, 2010
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor
Hitoshi Uchinoumi, Masafumi Yano, Takeshi Suetomi, et al.
Circulation
|
July 20, 2011
Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca²⁺release leading to catecholaminergic polymorphic ventricular tachycardia
Takeshi Suetomi, Masafumi Yano, Hitoshi Uchinoumi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 20, 2011
Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure
Takehisa Susa, Shigeki Kobayashi, Takeo Tanaka, et al.
International Journal of Hematology
|
February 21, 2022
Antibody response to COVID-19 vaccination in patients with lymphoma
Kentaro Narita, So Nakaji, Rikako Tabata, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Circulation Journal : Official Journal of the Japanese Circulation Society
|
April 7, 2012
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure
Shigeki Kobayashi, Takehisa Susa, Takeo Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 15, 2010
Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model
Shigeki Kobayashi, Masafumi Yano, Hitoshi Uchinoumi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 26, 2006
AT1 receptor antagonist restores cardiac ryanodine receptor function, rendering isoproterenol-induced failing heart less susceptible to Ca2+ -leak induced by oxidative stress
Takahiro Tokuhisa, Masafumi Yano, Masakazu Obayashi, et al.
Circulation
|
December 7, 2005
Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure
Masafumi Yano, Shinichi Okuda, Tetsuro Oda, et al.
European Journal of Heart Failure
|
October 23, 2010
Urinary 8-hydroxy-2'-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure
Shigeki Kobayashi, Takehisa Susa, Takeo Tanaka, et al.
Biochemical and Biophysical Research Communications
|
March 16, 2010
Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction
Xiaojuan Xu, Masafumi Yano, Hitoshi Uchinoumi, et al.
Circulation Research
|
March 13, 2010
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor
Hitoshi Uchinoumi, Masafumi Yano, Takeshi Suetomi, et al.
Circulation
|
July 20, 2011
Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca²⁺release leading to catecholaminergic polymorphic ventricular tachycardia
Takeshi Suetomi, Masafumi Yano, Hitoshi Uchinoumi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 20, 2011
Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure
Takehisa Susa, Shigeki Kobayashi, Takeo Tanaka, et al.
International Journal of Hematology
|
February 21, 2022
Antibody response to COVID-19 vaccination in patients with lymphoma
Kentaro Narita, So Nakaji, Rikako Tabata, et al.
Page
of 4